Mycoplasma Genitalium Infection: An Emerging Sexually Transmitted Infection

Mycoplasma Genitalium Infection: An Emerging Sexually Transmitted Infection

Mycoplasma Genitalium Infection: An Emerging Sexually Transmitted Infection
RestartResume
Dr. Geisler reviews the history of mycoplasma genitalium, as well as new testing methods and treatment options.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Mycoplasma genitalium was first reported 35 years ago.  The development of the research-based nucleic acid amplification tests (NAATs) has been the driving force behind the increased recognition of this infection. In this article we will discuss the history of the disease and review new and emerging diagnostic testing methods. Lastly, we will address treatment options and strategies for management of multi-drug resistant M. genitalium infections.

    To view the video introduction to the article, click here.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty: 
    William M. Geisler, MD, MPH
    Clinical Associate Director, Medical Scientist Training Program
    Professor of Medicine, Division of Infectious Disease
    University of Alabama at Birmingham

    Faculty’s disclosure
    Dr. Geisler has disclosed that he receives consulting fees from Hologic, Inc.

    Reviewers/Planners/Authors:

    • Ken Brown has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.

     

  • Learning Objectives

    1. Describe the burden and prevalence of disease in the general population and also specifically for women infected with M. genitalium.
    2. Understand the current availability of FDA-approved/unapproved testing methods in the U.S. for detecting M. genitalium.
    3. Employ appropriate treatment strategies when managing patients with M. genitalium infections.
  • Target Audience

    This activity is designed to meet the educational needs of the obstetrician and gynecologist, internal medicine physician, family physician, nurse practitioner, registered nurse, physician assistant.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

     

  • Commercial Support

    This activity is supported by an independent educational grant from Hologic Inc.

     

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Global Women's Health Academy newsletters.
Comprehensive Women's Health Education.

Better education for a better you.

* Required
Optional
Register

Join the Global Women's Health Academy of learners.
Registration is free and easy.

Register Now